{"status": "OK", "response": {"docs": [{"type_of_material": "Brief", "blog": [], "news_desk": "National", "lead_paragraph": "Patients given the blood-clot preventer Plavix after a heart attack or after receiving a stent have a far higher risk of heart attack or death in the three months after they stop taking the drug, researchers said.", "headline": {"main": "Risks With Heart Drug", "kicker": "National Briefing  | Health", "print_headline": "Risks With Heart Drug", "content_kicker": "National Briefing  | Health"}, "abstract": null, "print_page": "15", "word_count": "83", "_id": "547da6a7798810275e384cd2", "snippet": "Patients given the blood-clot preventer Plavix after a heart attack or after receiving a stent have a far higher risk of heart attack or death in the three months after they stop taking the drug, researchers said.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/02/06/us/06brfs-RISKSWITHHEA_BRF.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Plavix (Drug)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Heart", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Stents (Medical Devices)", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"person": [], "original": "By REUTERS", "organization": "REUTERS"}, "document_type": "article", "pub_date": "2008-02-06T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "Letter", "blog": [], "news_desk": "Letters", "lead_paragraph": "To the Editor:.", "headline": {"main": "Running Through the Cholesterol Maze", "sub": "(7 Letters)", "print_headline": "Running Through the Cholesterol Maze", "content_kicker": "Letters"}, "abstract": null, "print_page": "14", "word_count": "1056", "_id": "547d7f1b798810275e384921", "snippet": "To the Editor:.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2008/02/03/opinion/l03cholesterol.html", "multimedia": [{"subtype": "wide", "url": "images/2008/02/03/opinion/03letter.190h.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2008/02/03/opinion/03letter.190h.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2008/02/03/opinion/03letter.75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2008/02/03/opinion/03letter.75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Cholesterol", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Heart", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Statins (Cholesterol-Lowering Drugs)", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "6", "name": "organizations"}], "byline": null, "document_type": "article", "pub_date": "2008-02-03T00:00:00Z", "section_name": "Opinion"}], "meta": {"hits": 2, "offset": 0, "time": 38}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}